Tag Archives: patient-centred care

Introduction Our previous study on the efficacy and tolerability of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibiting monoclonal antibodies (mAbs), such as alirocumab and evolocumab, in real-world clinical practice confirmed significant and sustained reductions in LDL-C levels. These findings were observed in high-risk, statin-intolerant patients and others with known cardiovascular (CV) disease risks.1 Notably, our real-world results aligned with outcomes reported in pivotal trials, such as the ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) and FOURIE

The following expert faculty members have received an honorarium for participating at the meeting Faculty member Affiliation Professor Amitava Banerjee Professor of Clinical Data Science, Institute of Health Informatics, University College London; Consultant Cardiologist, University College London Hospitals and Barts Health NHS Trust Professor Sir Mark Caulfield Professor of Clinical Pharmacology, Queen Mary University of London & Vice-Principal for Health for Queen Mary’s Faculty of Medicine and Dentistry Professor Keith Fox Professor of Cardiology, University of Edinburgh & British Heart Foundation Professor of Cardio